Cardiometabolic risk factors among HIV patients on antiretroviral therapy

James N Kiage1, Douglas C Heimburger, Christopher K Nyirenda

  • 1Department of Medicine, Division of Epidemiology, Vanderbilt University, Nashville, TN 37203, USA.

Insights

Combination antiretroviral therapy (cART) in Zambia improved lipid profiles, reducing cardiovascular disease risk. However, short-term cART also showed a trend towards increased insulin resistance in HIV patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Metabolic Disorders

Background:

  • HIV and combination antiretroviral therapy (cART) are potential risk factors for cardiovascular disease (CVD).
  • This study investigated the early impact of cART on CVD risk markers in a low-risk population in Zambia.

Purpose of the Study:

  • To assess the short-term effects of initiating cART on cardiometabolic risk factors in HIV-infected adults.
  • To compare these effects across different cART regimens.

Main Methods:

  • Adult patients (n=118) initiating cART in Lusaka, Zambia, had cardiometabolic risk factors measured before and 90 days after treatment initiation.
  • Patients were categorized into three groups based on their cART regimen.
  • ANOVA was used to analyze changes in risk markers across regimens.

Main Results:

  • Low high-density lipoprotein cholesterol (HDL-c) prevalence decreased significantly (78.8% to 34.8%).
  • Elevated total cholesterol (TC) and insulin resistance (HOMA-IR ≥3.0) increased significantly.
  • The TC:HDL-c ratio ≥5.0 prevalence decreased significantly (44.9% to 6.8%).
  • These changes were independent of the specific cART regimen used.

Conclusions:

  • Short-term cART in this Zambian population was associated with a cardioprotective lipid profile.
  • A tendency towards increased insulin resistance was observed, irrespective of the cART regimen.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...